Cisplatin-induced apoptosis in human promyelocytic leukemia cells. 2006

Maurizio Previati, and Irene Lanzoni, and Elisa Corbacella, and Sara Magosso, and Valeria Guaran, and Alessandro Martini, and Silvano Capitani
Department of Morphology and Embryology, University of Ferrara, 44100 Ferrara, Italy. prm@unife.it

Cis-diamminedichloroplatinum (II) cisplatin (CDDP) is an organometallic compound frequently used in anti-cancer therapy, in particular ovarian, testicular, and head and neck tumors. We found cisplatin was effective against human promyelocytic leukemia cell line HL-60, inhibiting cell cycle progression and inducing time- and concentration- dependent cell death. Presence of nuclear fragmentation, caspase-3 cleavage and annexin V positivity suggests cell death occurred by apoptosis, although DNA internucleosomal fragmentation was not detected. In addition, analysis of malondialdehyde (MDA) production and protein carbonylation indicated that cisplatin increased lipid peroxidation and oxidation of cell proteins. This occurrence was prevented by antioxidants such as N-acetylcysteine (N-aC) and glutathione (GSH), which, consistently, were also able to prevent CDDP-induced cell death. Collectively, these findings indicate that, besides growth inhibition, an increase of oxygen radicals and lipid degradation can account for a significant part of CDDP-induced apoptosis.

UI MeSH Term Description Entries
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015473 Leukemia, Promyelocytic, Acute An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION. Leukemia, Myeloid, Acute, M3,Leukemia, Progranulocytic,Myeloid Leukemia, Acute, M3,Progranulocytic Leukemia,Promyelocytic Leukemia, Acute,AML M3,Acute Promyelocytic Leukemia,Leukemia, Acute Promyelocytic,M3 ANLL,ANLL, M3,Acute Promyelocytic Leukemias
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D050050 Protein Carbonylation The appearance of carbonyl groups (such as aldehyde or ketone groups) in PROTEINS as the result of several oxidative modification reactions. It is a standard marker for OXIDATIVE STRESS. Carbonylated proteins tend to be more hydrophobic and resistant to proteolysis. Carbonylation, Protein,Carbonylated Protein Formation,Protein Carbonyl Formation,Carbonyl Formation, Protein,Carbonylations, Protein,Protein Carbonylations

Related Publications

Maurizio Previati, and Irene Lanzoni, and Elisa Corbacella, and Sara Magosso, and Valeria Guaran, and Alessandro Martini, and Silvano Capitani
December 2003, Annals of the New York Academy of Sciences,
Maurizio Previati, and Irene Lanzoni, and Elisa Corbacella, and Sara Magosso, and Valeria Guaran, and Alessandro Martini, and Silvano Capitani
January 2005, Bioscience, biotechnology, and biochemistry,
Maurizio Previati, and Irene Lanzoni, and Elisa Corbacella, and Sara Magosso, and Valeria Guaran, and Alessandro Martini, and Silvano Capitani
January 2016, Biomarker insights,
Maurizio Previati, and Irene Lanzoni, and Elisa Corbacella, and Sara Magosso, and Valeria Guaran, and Alessandro Martini, and Silvano Capitani
February 2004, Clinica chimica acta; international journal of clinical chemistry,
Maurizio Previati, and Irene Lanzoni, and Elisa Corbacella, and Sara Magosso, and Valeria Guaran, and Alessandro Martini, and Silvano Capitani
December 2003, Experimental & molecular medicine,
Maurizio Previati, and Irene Lanzoni, and Elisa Corbacella, and Sara Magosso, and Valeria Guaran, and Alessandro Martini, and Silvano Capitani
June 2012, Journal of proteomics,
Maurizio Previati, and Irene Lanzoni, and Elisa Corbacella, and Sara Magosso, and Valeria Guaran, and Alessandro Martini, and Silvano Capitani
September 2002, Yao xue xue bao = Acta pharmaceutica Sinica,
Maurizio Previati, and Irene Lanzoni, and Elisa Corbacella, and Sara Magosso, and Valeria Guaran, and Alessandro Martini, and Silvano Capitani
January 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Maurizio Previati, and Irene Lanzoni, and Elisa Corbacella, and Sara Magosso, and Valeria Guaran, and Alessandro Martini, and Silvano Capitani
October 2000, Biochemical pharmacology,
Maurizio Previati, and Irene Lanzoni, and Elisa Corbacella, and Sara Magosso, and Valeria Guaran, and Alessandro Martini, and Silvano Capitani
August 2018, Oncology reports,
Copied contents to your clipboard!